Statins, bugs and prophylaxis: intriguing possibilities. - Wikidata - awgldk - TriplyDB

Statins, bugs and prophylaxis: intriguing possibilities.

Statins, bugs and prophylaxis: intriguing possibilities.

http://www.wikidata.org/entity/Q30357923

about

Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice Statin research in critical illness: hampered by poor trial design?Are there any benefits from statin treatment for the septic patient?Impact of statins in outcomes of septic patients: a systematic review.Statin therapy in critical illness: an international survey of intensive care physicians' opinions, attitudes and practice.Mechanisms of action and efficacy of statins against influenza.Statins and influenza: can we move forward?

P2860

Q35567062-FF65B007-1F69-4BD8-9774-C929ACC356FF Q36607954-2C0765A6-D86F-48C3-9B92-292EFECF858E Q37657764-3960BBCF-8B05-4F7E-8FED-8AE8F37F9C18 Q38166322-01764924-15AB-4D4D-A4B3-ABC13E4D6804 Q38267132-77D48E34-94AE-4B1C-9E10-6686AA1CFA2D Q42016440-6763F8BA-E190-48F4-B9F6-4EEBEA58D49A Q42177559-0C5C574C-A76A-43B4-AA63-F9BA50C44DD7 Q43023894-E60B6B28-4C27-43EE-9BFE-7ACD75043AB0

P2860

Statins, bugs and prophylaxis: intriguing possibilities.

http://www.wikidata.org/entity/Q30357923

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Statins, bugs and prophylaxis: intriguing possibilities.

@ast

Statins, bugs and prophylaxis: intriguing possibilities.

@en

type

label

Statins, bugs and prophylaxis: intriguing possibilities.

@ast

Statins, bugs and prophylaxis: intriguing possibilities.

@en

prefLabel

Statins, bugs and prophylaxis: intriguing possibilities.

@ast

Statins, bugs and prophylaxis: intriguing possibilities.

@en

P1433

Q30357923-1ED779E7-89C9-4FCA-86EC-42C6117B6423

P1476

Q30357923-136604C9-8516-495A-9DD6-23423736580A

P2093

Q30357923-73E6764D-7469-470E-998B-932D8B05D8AD

Q30357923-9E8E1CAB-B2B1-4281-84C5-4B4A1E14A68A

P2860

Q30357923-1482A183-B2E2-4BD9-985D-CA90388D9DBC

Q30357923-245AD1BC-B9B3-43AF-AB6F-A48EC1B3C552

Q30357923-41A9A0C3-06B9-43B4-A919-04492CFB7B0C

Q30357923-435A7F1A-D178-4A51-B91C-2B6984762983

Q30357923-4AF6AAD0-8F6B-496A-9E22-D870EB466E5D

Q30357923-561C4487-4CE6-4E5A-B706-1F4A8C45E282

Q30357923-5E9060B8-366E-48AB-9B0A-234DB8235412

Q30357923-62893A79-BD1E-422F-83B6-FA902A4CE164

Q30357923-6DA55375-731E-4FD0-B8E7-8B103B1E1DF6

Q30357923-752D8C3B-D51D-4DD3-A93D-8149F15442D9

P2888

Q30357923-43212A8D-B767-4479-A8CD-C4AC7616E4D6

P304

Q30357923-14901C04-B3B3-45AB-92DB-E5B64E0C3758

P31

Q30357923-367B7FAE-AE96-4AB8-96F8-CAB83996AF6E

Q30357923-84742C01-7862-4A5E-A91D-F763A961027F

P356

Q30357923-D749016B-C399-40D6-8698-1B7192CD9C56

P433

Q30357923-47182AD8-244C-49ED-AF4B-D40199C97462

P478

Q30357923-9C1FBE41-CC13-4A9A-BC9C-7E79402F3B0E

P50

Q30357923-9C1005BF-6E0F-44A8-A39A-4EFB4A0BEB01

P577

Q30357923-58D7971E-97C2-480A-8109-BDB58DDA32C2

P5875

Q30357923-563EB9AE-99ED-4CF1-8FEC-FE6EAABAEDDD

P6179

Q30357923-DBF1EC3B-8781-4A9C-9D2E-6B0065EF9ECE

P698

Q30357923-7E959764-D834-4641-B57E-5C2C34E7344A

P921

Q30357923-EB4221AA-BFBA-47C3-9270-329EE785A4D1

Q30357923-F2F3204B-E713-46BB-83D3-756A274C676B

P932

Q30357923-C431888D-5285-48BB-9416-DC8D01E98F17

P356

P1433

P1476

Statins, bugs and prophylaxis: intriguing possibilities.

@en

P2093

Neill K J Adhikari

http://www.w3.org/2001/XMLSchema#string

Terry S Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

Re-emergence of fatal human influenza A subtype H5N1 disease

Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro

In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans

The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells.

Vaccine development for an imminent pandemic: why we should worry, what we must do.

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.

Beyond lipid lowering: the role of statins in vascular protection.

Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation

P2888

P304

168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC5056

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Marius Terblanche

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6702197

http://www.w3.org/2001/XMLSchema#string

P6179

1024736165

http://www.w3.org/2001/XMLSchema#string

P698

17094793

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

P932

1751082

http://www.w3.org/2001/XMLSchema#string